The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
SPES Tech Limited is a Hong Kong biotechnology startup specialized in the development of well-defined biomaterials via protein and genetic engineering techniques. Our proprietary hydrogel technology platform, highly mimicking the in-vivo microenvironment, enables more physiologically relevant 3D cell models for the next-generation of drug screening in a more predictive way and high throughput manner.
The company’s proprietary recombinant protein technology enables the paradigm shift of cell culture towards more physiologically relevant platforms. It provides a board portfolio of xeno-free tunable hydrogels to closely mimic the natural extracellular matrix for different types of cells to grow like in vivo. The flagship product LitGel leverages non-invasive light control to release cells after cultivation, realizing harmless cell harvesting. It also provides smart controlled bioinks for tissue engineering in high precision. Incorporating the hydrogel technology as an injectable carrier for cell therapy, researchers can achieve better cell retention, higher cell viability, and greater proliferation to restore human health.